With so many weight loss medications on the market, it's easy to feel overwhelmed by the options. From brand-name heavy ...

It is made possible through a first-of-a-kind integration with Eli Lilly’s direct-to-consumer website, and aims to streamline ...

For the uninitiated, both Zepbound (tirzepatide) and Wegovy (semaglutide) are weight loss drugs. They target hormones that ...

Direct-to-consumer health and wellness company Ro will now offer access to lower-priced, single-dose vials of weight loss ...

Telehealth company Ro said on Wednesday it will provide access to single-dose vials of Eli Lilly's weight-loss drug Zepbound ...

These weight loss drugs are expensive out of pocket, though. Even with insurance, high co-pays can also limit who has access ...

Eli Lilly is partnering with the Flatiron-based telehealth company Ro to sell a cheaper version of its popular weight-loss ...

Patients self-administer the drug using a pre-dosed injector pen, but Lilly recently introduced the product in single-dose ...

Zepbound outperformed Wegovy for weight loss in a new clinical trial funded by Eli Lilly & Co., Zepbound's maker.

Prescriptions for weight-loss drugs surged in 2024 and were much more popular in some states, particularly those in the South ...

Zepbound (tirzepatide) is a prescription drug that’s used for weight loss in certain adults. Zepbound comes as a liquid solution inside prefilled injection pens. You’ll inject the drug under ...

Eli Lilly strikes Zepbound deal with the telehealth platform Ro, amid questions about future of compounded GLP-1s.